These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30204289)

  • 1. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
    Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
    Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination.
    Isfordink CJ; van Dijk M; Brakenhoff SM; Kracht PAM; Arends JE; de Knegt RJ; van der Valk M; Drenth JPH;
    Eur J Intern Med; 2022 Jul; 101():93-97. PubMed ID: 35527178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.
    van Dijk M; Kracht PAM; Arends JE; Blokzijl H; Burger DM; van Erpecum KJ; van Hoek B; de Knegt RJ; Posthouwer D; Ramsoekh D; Rijnders BJA; Schinkel J; Willemse SB; van der Valk M; Drenth JPH; Behalf Of The HepNed Study Group O
    Neth J Med; 2019 May; 77(4):131-138. PubMed ID: 31502544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.
    Heil J; Soufidi K; Stals F; Frantzen H; Robroek-Schaecken A; Bakker CM; van Nunen AB; Dukers-Muijrers NHTM; Hoebe CJPA
    Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):851-856. PubMed ID: 31688310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C.
    Isfordink CJ; Brakenhoff SM; van Dijk M; van der Valk M; de Knegt RJ; Arends JE; Drenth JP;
    BMJ Open Gastroenterol; 2020; 7(1):e000396. PubMed ID: 32377367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up.
    Chen CJ; Huang YH; Hsu CW; Chen YC; Chang ML; Lin CY; Shen YH; Chien RN
    BMC Gastroenterol; 2023 Feb; 23(1):40. PubMed ID: 36782112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrieval of chronic hepatitis B patients in the Utrecht region in the Netherlands.
    Dimmendaal M; Kracht PAM; Dijkstra S; Arends JE; Woonink F; Behalf Of The Reach Working Group O
    Neth J Med; 2019 Aug; 77(6):199-203. PubMed ID: 31391325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis.
    Kracht PAM; Arends JE; Hoepelman AIM; Kretzschmar MEE
    BMC Infect Dis; 2021 Jul; 21(1):640. PubMed ID: 34217261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.
    Rusch U; Robbins S; Razavi H; Vernazza P; Blach S; Bruggmann P; Müllhaupt B; Negro F; Semela D
    Swiss Med Wkly; 2019 Jan; 149():w14694. PubMed ID: 30673118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrieval of patients with hepatitis C who were lost to follow-up in Southern Denmark.
    Dröse S; Hansen JF; Røge BT; Øvrehus ALH; Christensen PB
    Infect Dis (Lond); 2023 May; 55(5):361-369. PubMed ID: 36930953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.
    van Dijk M; Drenth JPH;
    J Viral Hepat; 2020 Dec; 27(12):1270-1283. PubMed ID: 32964615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy.
    Wong GL; Chan HL; Loo CK; Hui YT; Fung JY; Cheung D; Chung C; Chim AM; Wong VW;
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1641-1647. PubMed ID: 30707777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
    Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
    Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balancing perspective of hard-to-reach hepatitis C patients who were lost to follow-up: A qualitative study.
    Kracht PAM; Arends JE; Hoepelman AIM; Vervoort SCJM
    PLoS One; 2020; 15(4):e0230756. PubMed ID: 32282805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.